Data for: SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type

Published: 16-07-2020| Version 1 | DOI: 10.17632/sfh4bs7p54.1
Contributor:
Jingwen Wang

Description

None.

Files